Primary Site >> Biliary tract Cancer
Gene >> CDH3
|
|
|
|
|---|---|---|---|
|
Ref: [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept]. PMID: 16897967 |
Ref: Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. PMID: 16786333 |
Ref: Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. PMID: 20621328 Ref: CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. PMID: 21189991 |
Ref: Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer. PMID: 24606884 |